Pseudomonas aeruginosa is the most prominent colonizer of the respiratory tract of patients with cystic fibrosis, but it is not known why this occurs. P. aeruginosa adheres to mucins from normal individuals, but mucins from cystic fibrosis patients have not been studied. To compare adhesion to mucins from cystic fibrosis with other mucins, we prepared highly glycosylated mucin glycopeptides from cystic fibrosis and chronic bronchitis patients by ion-exchange and gel-tiftration chromatography and measured the adhesion of P. aeruginosa 1244 to these glycopeptides. We found (i) that the most mucinlike glycopeptides from P. aeruginosa-infected cystic fibrosis sputa showed less bacterial adhesion than did the corresponding bronchitis samples, (ii) that the most adhesive activity in cystic fibrosis samples came from a fraction that contains 0 and N glycopeptides and may be in part a degradation product of P. aeruginosa infection, and (iii) that highly glycosylated glycopeptides of the most acidic species (sialylated and sulfated) showed no adhesion at all. A single cystic fibrosis sample not infected by P. aeruginosa showed better binding in the adhesion-positive fractions than did the infected sputa. These studies suggest that cystic fibrosis mucins may be altered after infection is established, resulting in less binding to some fragments. However, since the clinical picture shows heavy mucus colonization, other receptors, such as cellular glycolipids which have been shed into mucus, may be contributing to this colonization.
The reason for the predominance of Pseudomonas aeruginosa as the colonizing bacterium in cystic fibrosis (CF) is not known. However, this organism adheres to respiratory mucins much more avidly than other gram-negative bacteria do (23) and possesses adhesins for mucins (15) . This specificity for mucins may be a clue to explain this unique predisposition, but in comparisons of the binding of P. aeruginosa to whole normal chronic bronchitic (CB) mucin and CF mucin, the CF mucins prepared so far do not show greater adhesion (Ramphal, unpublished observations) . Nevertheless, the remarkable tropism of P. aeruginosa that is observed clinically and the binding specificity of this organism for mucins suggest that there may be an explanation that involves CF mucins. We hope to find an explanation for this specificity by comparing the adhesion of P. aeruginosa to subfractions of mucins isolated from both CF and non-CF mucins. By studying adhesion in this fashion we may be able to (i) ascertain whether there is, indeed, a difference in the binding of P. aeruginosa to different mucins and (ii) eventually compare the structures of binding and nonbinding fractions to study any specificity found. This latter step would be extremely difficult with whole mucins, which have molecular weights greater than 106 (20) and possibly contain hundreds of different oligosaccharides (4, 8) as well as associated glycolipids (5) .
Mucins appear to have carbohydrate chains of differing acidity clustered on highly glycosylated regions of the polypeptide chain(s) (20) . If crude mucus is reduced and then digested, the resulting mucin glycopeptides and peptides can be separated according to their net charge. Ion-exchange chromatography on ECTEOLA-cellulose resin, with in-* Corresponding author.
creasing concentrations of NaCI-HCl as the eluting agent, yields fractions called F1, F2, and F3. F1, the fraction that is not retained on the column, is called the neutral fraction by definition. F2, which is eluted by 0.1 M NaCl-0.01 N HCl, is slightly acidic because of the sialic acid residues present. F3, the most acidic fraction, by virtue of the presence of sialylated and/or sulfated oligosaccharide chains is eluted by 1 M NaCl-0.1 N HCl.
These fractions can be further purified by gel filtration on Sepharose 4B to give the most highly glycosylated glycopeptides corresponding to the above fractions as follows: Flb and F1c from F1, F2b from F2, and F3a from F3. Since the evidence suggests that the P. aeruginosa receptor in mucins is carbohydrate in nature (24), we have directed our attention to these highly glycosylated fractions.
In the studies described below we present evidence for differences in the binding of P. aeruginosa to the highly glycosylated subfractions of mucins. However, no specificity for CF mucin was found; instead, there appeared to be less binding to CF mucin glycopeptides after infection had occurred, and some of the most highly glycosylated mucin fractions failed to bind this organism.
MATERIALS AND METHODS
Collection of bronchial secretions. Coughed sputum was collected from 14 patients during hospitalization for respiratory failure. Volumes of between 200 ml and 1 liter were collected and immediately frozen at -20°C until they were used to prepare the mucin glycopeptides. Sputa were collected from three CB patients and pooled, from four individual CB patients and kept separately, from three CF patients with P. aeruginosa infection and pooled, from three individual CF patients infected with P. aeruginosa and kept sepa- (-) and for A278 (---). Fractions indicated by bars were dialyzed and lyophilized. Profiles A, C, and E correspond to bronchial glycopeptides from a CB sputum not infected by P. aeruginosa, and profiles B, D, and F correspond to bronchial glycopeptides from a CF sputum infected by P. aeruginosa.
rately, and from one CF patient without P. aeruginosa infection.
Preparation of mucin glycopeptides. The sputa were thawed at room temperature and reduced in phosphate buffer by 2-mercaptoethanol (Eastman Kodak Co., Rochester, N.Y.) as described previously (10) . The reduced secretions were then dialyzed, lyophilized, and digested by pronase (Pronase R protease; Calbiochem, San Diego, Calif.) in 0.01 M calcium acetate buffer (pH 7.0), by using an enzyme/ substrate ratio of 1:40, at 37°C. After 24 h the secretions were centrifuged, and the supernatants were dialyzed and lyophilized.
Separation of mucin glycopeptides by ion-exchange chromatography. The crude preparations of glycopeptides from the preceding steps were separated according to acidity on an ECTEOLA-cellulose column (Bio-Rad Laboratories, Richmond, Calif.) as described previously (10) . Three fractions were eluted by increasing concentrations of NaCl and HCl. These were dialyzed and then lyophilized.
Separation of mucin glycopeptides by gel filtration. The glycopeptides, which were separated according to charge, i.e., neutral (F1), slightly acidic (F2), and acidic (F3), were then further separated by gel filtration on Sepharose 4B (Pharmacia, Uppsala, Sweden) to separate the most highly glycosylated fractions, called F1b, F1c, F2b, and F3a, from contaminants such as peptides and nucleic acids (10) .
Characterization of the highly glycosylated fractions. (i) Chemical composition. Each highly glycosylated fraction was analyzed for amino acid (10) and carbohydrates by a quantitative gas-liquid chromatographic method (8) , and neuraminic acid was measured by the thiobarbituric acid assay (1) . Sulfate was measured only in the case of the most acidic fractions (21) .
(ii) Polyacrylamide gel electrophoresis. Polyacrylamide (5 to 15%) gel slabs were prepared by the method of Kerckaert (6), and electrophoresis was conducted with the buffer system of Laemmli (7). Protein standards were the molecular weight electrophoresis kit from Pharmacia, and the glycoprotein standard was serum a-glycoprotein from Sigma Chemical Co. (St. Louis, Mo.). After electrophoresis, proteins were stained with Coomassie brilliant blue 5250 (BDM, Dorset, England), and the carbohydrates were stained by a Schiff reagent procedure (25) .
Adhesion studies. P. aeruginosa 1244, a piliated strain that has been described in previous studies (17) , was used to test adhesion to the highly glycosylated glycopeptide fractions. The bacteria were grown overnight at 37°C in Trypticase soy broth (Difco Laboratories, Detroit, Mich.), pelleted by centrifugation, and washed with phosphate-buffered saline (pH 7.0). They were then suspended in phosphate-buffered saline at a predetermined optical density to give an inoculum between 5 x 106 and 8 x 106 CFU/ml. The adhesion assay has been described previously (23) . It was modified by omitting siliconization of the polystyrene microdilution (2) and tested to ensure that they were bound to the microdilution plates. In brief, 1 mg of each sample was dissolved in 1 ml of 0.1 M acetate buffer (pH 5.5) with 0.02% sodium azide. Then 10 RI of 1 M sodium periodate was added, and the mixture was kept in the dark for 20 min on ice. Glycerol was then added at a final concentration of 15 mM for 5 min at 0C, and then the oxidized samples were dialyzed at 4°C in the dark overnight. Biotin hydrazide (Pierce Chemical Co., Rockford, Ill.) in powder form was added at 10 mM concentration, and the mixture was stirred for 72 h at 4°C. The samples were then dialyzed in the dark overnight. The wells of a microdilution plate were then coated overnight with 0.1 ml of biotinylated glycopeptides at 100 ,ug/ml, and binding to the wells was detected by streptavidin peroxidase by using 2,2-azino-bis(3-ethyl-benzthiazoline-6-sulfonic acid) (Sigma) and hydrogen peroxide as the revealing agents. Plates were read in a Titertek Multiscan plate reader (Flow) at 414 nM. Controls included whole mucins and F1b fractions, which were known to give bacterial binding.
RESULTS
Characteristics of the highly glycosylated mucus glycopeptides. The three fractions of increasing acidic character that were obtained after ion-exchange chromatography of the crude mucin glycopeptides (F1, F2, and F3) were further purified on Sepharose 4B. The elution profiles of these fractions from a CB sputum not infected by P. aeruginosa and a CF sputum infected by P. aeruginosa are shown in Fig. 1A . The differences visualized in the neutral glycopeptide fractions (Fig. 1A and B) were analyzed elsewhere (5a). To recapitulate, concurrent with P. aeruginosa infection, the F1b fraction was always greatly diminished in quantity (Table 1 ) when compared with noninfected sputa. In contrast, the Flc fraction was always greatly increased ( Table   1 ). The composition of F1b was that of 0-glycosylated glycopeptides, and F1c appeared to be a mixture of 0-and N-glycosylated glycopeptides (Table 2 ). The slightly acidic fraction F2b, which is highly glycosylated (19) , had a similar profile in both types of mucus ( Fig. 1C and D) and was similar in yield (Table 1 ) and chemical composition ( Table 2 ). The chemical compositions are those of true 0-glycosylated mucin glycopeptides.
Gel filtration of the most acidic fractions (F3) allowed the separation of nucleic acids from the mucin glycopeptides ( Fig. 1E and F) . The chemical compositions of the remaining F3a glycosylated fractions were also very similar in sugar and amino acid content and were those of acidic mucins because of the concentrations of sialic acid and sulfate.
Thus, in a general sense all of these glycopeptides (F1b, Flc, F2b, and F3a) were qualitatively similar in the two patient groups (CF and CB).
Electrophoretic studies. Polyacrylamide gel electrophoresis of the four glycosylated fractions described above is shown in Fig. 2 . One patient from each population is depicted. Fractions F1b, F2b, and F3a behaved like true mucin glycopeptides, i.e., they partially migrated out of the stacking gel, were strongly stained by periodic acid-Schiff stain, and were not contaminated by proteins. In contrast, the Flc fractions, the mixture of small glycoproteins (included in Sepharose 4B), showed many protein bands in both samples and two periodic acid-Schiff-stained bands that also stained by Coomassie blue, uniquely in the P. aeruginosa- infected samples. These bands were characterized previously (5a). This is the only difference found in the sputum samples to date. The two unique bands appear to be associated with P. aeruginosa infection of mucus.
Adhesion. (i) Glycopeptides from pooled sputa. The adhesion studies on the pooled sputa from the two patient populations showed remarkable differences (Table 3 ). In the CB pool, adhesion was greatest in the neutral Flb and slightly acidic F2b fractions, which were more characteristic of true mucins, with a small amount in the Flc fraction. In the CF pool, adhesion was greatest in the F1c fraction, which may contain degradation products, probably from F1b (5a). The F2b fraction from the CF pool showed less adhesion than that of the CB pool, but neither F3a fraction (the most acid fraction) showed binding.
(ii) Glycopeptides from individual patients. Adhesion studies on individual patients partially confirmed the results obtained with the pooled sputa. However, there was great variability from one patient to another (Table 4) . When the noninfected CF sample was separated and the respective CB and CF values were pooled, there was less binding to the CF F1b and F2b fractions than to the CB fractions (Table 5 ), but the differences in the F1c fractions that were seen with the pools were no longer present. Again, none of the F3a fractions bound bacteria. Interestingly, the noninfected CF patient samples showed binding only to the neutral fractions, in numbers greater than those in both the CB and infected CF samples.
Yield of glycopeptides versus adhesion. Examination of the yields of the glycopeptides versus adhesion (Table 5) suggested that most of the adhesion to the infected CF mucus occurred with fraction F1c, which contained a mixture of 0-and N-glycosylated glycopeptides and peptides. This fraction is largest in quantity (12.3%) and shows the highest adhesion. The mucin glycopeptides, F1b, F2b, and F3a, which did not contain N glycopeptides and which made up 10.8% in total of infected mucus, were much lower in binding capacity. The noninfected CF sample showed most of its binding in the neutral fractions F1b and F1c, which made up about half of the glycopeptides recovered. The largest fraction of the noninfected CF sample, the sulfated fraction F3a (20.1%), was devoid of binding activity. Therefore, it would appear that P. aeruginosa infection may cause or be associated with a lowered binding capacity to all of the most highly 0-glycosylated glycopeptide portions of mucus. F3 binding to the microdilution plates. The striking finding that the F3a fractions from all sputa were adhesion negative, despite the high degree of glycosylation, led us to study F3a binding to the microdilution plates (Table 6 ). All F3a fractions were bound to the plates in quantities at least as great as the F1b fractions, which showed good adhesion. Therefore, there must be structural features of F3a that prevented adhesion, even though the sugar composition was similar to that of the other fractions (Table 2) . DISCUSSION These studies involving the sputum samples of 14 patients with CB or CF indicate that there are differences in bacterial The fact that the sulfated fractions showed no binding is particularly intriguing and may provide some understanding as to the functions of sulfation of mucins. Sulfation may result in chain termination of oligosaccharides and commonly occurs in some chronic obstructive lung diseases (9), including CF (3). Therefore, if bacterial binding to stagnant mucus is a pathogenetic mechanism in chronic obstructive lung diseases, then sulfation may be a mechanism to reduce binding. Sulfation does appear to alter recognition, since sulfation of the i antigen masks its recognition by some monoclonal antibodies (22) and sulfated glycosaminoglycans prevent the adhesion of bacteria to the urinary bladder (13) . Although sulfate groups may provide this nonadhesive property to these glycopeptides, the sequences of the oligosaccharide chains themselves could also be the reason. Some of the nonsulfated oligosaccharide sequences from CF F3a fractions are known, but nothing unique has been found in this fraction to date (19) . The sulfated oligosaccharide chains that have been elucidated also do not show any unique oligosaccharide sequences (12) . Removal of the sulfate groups without altering the oligosaccharide chains could provide an answer as to whether the sulfate groups are blocking adhesion, but attempts to desulfate these fractions have resulted in the loss of fucose and sialic acid (Ramphal and Lamblin, unpublished observations). The fact that CB mucus and noninfected CF mucus have high contents of sulfated glycopeptides (Table 5 ) may be significant, in that P. aeruginosa is absent from these patients, and leads us to ask whether the high sulfated glycopeptide content plays a protective role. Alternately, Pseudomonas infection could be reducing the sulfated fractions.
The significance of the other findings is not clear at this time. There appear to be mechanisms that both increase and decrease binding to CF mucus; e.g., there is less of F1b in P. aeruginosa-infected CF mucus and less binding to this fraction when compared with those in noninfected CF mucus. In contrast, there is less binding to F1c of infected CF when compared with noninfected CF but more of this fraction in infected CF. There are significant amounts of F2b and more binding in infected CF and a virtual absence in the noninfected CF samples. If one concludes that the native state of binding in CF is that seen in the noninfected CF sample, then all of these changes probably result from infection. Similarly, the F1b and F2b fractions of infected CF mucus also show reduced binding when compared to CB fractions. Thus the glycopeptides from infected CF mucus shows some puzzling factures, i.e., reduced binding, reduced F1b fractions, and the appearance of an F1c fraction, all of which may be the result of infection.
The genesis of these differences in adhesion is speculative. It is not known whether there are differences in the glycosylation of the mucin of CF patients before versus after infection, nor whether CF mucin is different from other mucins; increased sulfation of CF mucin has, however, been reported (3, 9) . There is good evidence that mucin break-down is taking place in infected CF mucus (5a, 18) , and one recent study indicates that both P. aeruginosa elastase and neutrophil elastase are capable of degrading mucins (14) . In addition, neuraminidase from P. aeruginosa capable of releasing sialic acid from mucin has been described (11) . Thus, the differences seen in the binding of P. aeruginosa to the mucin glycopeptides may be the result of enzymatic activity. How these differences in adhesion and this possible degradation fit into the scheme of the pathogenesis of P. aeruginosa infection in CF is not clear at this time. It could be speculated that when there is some residual mucociliary clearance in CF, mucin degradation leading to decreased adhesion could protect the organism from removal.
It is clear from the above studies that it will require the study of many noninfected CF patients to answer the question of a specific tropism of P. aeruginosa for CF mucins. In addition, because of amount of adhesion-positive material is so low among the mucin glycopeptides of infected CF mucus, other receptor materials in infected CF mucus, e.g., membrane glycolipids (16) , may be playing a role in mucus colonization.
